Clinical Trials Browser

NIH × Neuroectodermal Tumors, Primitive, Peripheral × Sorafenib × Clear all

NCT00330421 2014-04-30

Sorafenib in Treating Patients With Soft Tissue Sarcomas (Extremity Sarcoma Closed to Entry as of 5/30/07)

Phase 2 Completed

15 enrolled 7 charts

Sarcoma, Osteosarcoma, Neuroectodermal Tumors, Primitive, Peripheral